Publication | Closed Access
Evaluation of the effect of the specific CCR1 antagonist CP‐481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects
13
Citations
17
References
2008
Year
Blocking of CCR1 only partly inhibited clinical manifestations of ACD. Several chemokine receptors are likely relevant for the cellular influx observed in ACD lesions.
| Year | Citations | |
|---|---|---|
Page 1
Page 1